CIO Symposium on Clinical Interventional Oncology 2018

10 $

‘+ Include: 80 videos, size: 18 GB

+ Target Audience: oncologist

Description

+ Include: 80 videos, size: 18 GB

+ Target Audience: oncologist

+ Sample video: contact me for sample video

+ Topics:

Session 1 – Current State of the Art in Liver Tumor Detection and Treatment Planning.mp4
Session 1 – HCC Panel What Riccardo Lencioni Missed.mp4
Session 1 – Liver Case Review 9.5 cm Liver Mass- HCC.mp4
Session 1 – Liver Case Review History of Heb B HCC.mp4
Session 1 – Liver Case Review Mass in Transverse Colon With Liver Metastasis in Right and Left Lobes.mp4
Session 1 – Mets Panel What Dan Sze Missed.mp4
Session 1 – Set Proton Beam on Stun Radiation Oncology in the Liver.mp4
Session 1 – Weekend Update HCC Year in Review.mp4
Session 1 – Weekend Update Liver Metastatic Disease Year in Review.mp4
Session 1 – What Everyone, Including the Medical Oncologist, Missed A Surgeon’s View.mp4
Session 1 – What IO Missed in Colorectal and Liver Cancer A Medical Oncologist’s View.mp4
Session 2 – Buzzkill Corner The Existential Threats to Interventional Oncology and the Possible Solutions.mp4
Session 2 – Declaring Mistrials What to Make of the Negative IO Studies and Other Literature Conundrums – SARAH SIRVENIB Trials.mp4
Session 2 – Declaring Mistrials What to Make of the Negative IO Studies and Other Literature Conundrums 1.mp4
Session 2 – Declaring Mistrials What to Make of the Negative IO Studies and Other Literature Conundrums 2.mp4
Session 2 – Interpreting Trials Local Treatment of Unresectable Colorectal Liver Metastases.mp4
Session 2 – Review of the SIRFLOX-FOXFIRE Trials.mp4
Session 2 – The Big Picture The Value of IO in a Major Cancer Center.mp4
Session 2 – Transarterial Trials with Potential Confounders.mp4
Session 3 – Cirrhosis Case Study Liver Radiation Lobectomy.mp4
Session 3 – Conventional TACE.mp4
Session 3 – cTACE Case Study.mp4
Session 3 – Drug-Eluting Embolics.mp4
Session 3 – Liver Ablation.mp4
Session 3 – Liver Isolation In Interventional Oncology.mp4
Session 3 – Radial Access in IO.mp4
Session 3 – The Fun Part Operator’s Session in Liver-Directed Therapy.mp4
Session 3 – Y-90.mp4
Session 4 – Case Study Intermediate Grade Neuroendocrine Tumor (NET).mp4
Session 4 – Case Study Metastatic Colorectal Cancer Confined to the Liver.mp4
Session 4 – Day 1 Roundup What I Learned and Audience Q&A.mp4
Session 4 – Dosimetry Review for the Impatient IO.mp4
Session 4 – Heads Up Red Flags and Cautions in Y90.mp4
Session 4 – Special Considerations in Y90 Shunts, PVT, and Non-Target Embolization Protection.mp4
Session 4 – The Big Picture The Many Uses of Y90 in the Liver (and Beyond).mp4
Session 4 – Weekend Update Y90 Year in Review.mp4
Session 4 – Workout at the Y HCV Cirrhosis Radioembolization Case Presentation.mp4
Session 4 – Workout at the Y Low Grade HCC Radioembolization Cases.mp4
Session 4 – Workout at the Y Operator’s Session on Radioembolization Cases Cases Review – High LSF PVT – dose fractionation.mp4
Session 5 – Cases You Should Be Doing Operator’s Session on Lung Ablation.mp4
Session 5 – Lung Ablation Breathing New Life or Last Gasp Cases You Should Be Doing.mp4
Session 5 – Lung Ablation Cases You Should Be Doing.mp4
Session 5 – Lung Cryo Ready for Prime Time Cases You Should be Doing Operators Session Lung Ablation.mp4
Session 5 – Lung Cryo Ready for Prime Time.mp4
Session 5 – Not So Fast The Role of SBRT.mp4
Session 5 – The Case for Lung Ablation Why You Should Be Doing It.mp4
Session 5 – Weekend Update Lung Ablation Year in Review.mp4
Session 6 – Interventions for Adrenal Malignancy.mp4
Session 6 – Interventions for Pancreatic Cancer.mp4
Session 6 – Interventions for Prostate Cancer IO, Prostate Fusion Biopsy & Focal Therapy Options.mp4
Session 6 – Liver Only Metastatic Disease Live Case Discussion.mp4
Session 6 – Lymph Node and Soft Tissue Metastasis Ablation.mp4
Session 6 – Stage One Breast Cancer with Metastatic Disease to Vertebral Body Case Presentation.mp4
Session 6 – Thyroid Ablation Wait for It, It’s Coming. No, It’s Already Here.mp4
Session 6 – Tumor Necrosis in Conventional Versus Drug-Eluting Bead.mp4
Session 7 – Craftsman’s Corner Operator’s Session in Renal Ablation Intervention Gervais 1.mp4
Session 7 – Craftsman’s Corner Operator’s Session in Renal Ablation Intervention Gervais 2.mp4
Session 7 – Operator’s Session in Renal Ablation Interventions.mp4
Session 7 – Renal Cell Carcinoma Year in Review.mp4
Session 8 – Craftsman’s Corner Operator’s Session in MSK Interventions- Desmoid Tumor Cryoablation.mp4
Session 8 – Craftsman’s Corner Operator’s Session in MSK Interventions.mp4
Session 8 – Osteoid Osteomas Craftsman’s Corner.mp4
Session 8 – Weekend Update MSK Year in Review.mp4
Session 9 – Academic Center IO There is No Substitute for a Transplant Center.mp4
Session 9 – Private Practice IO Patients Prefer the Private Touch.mp4
Session 9 – Role of the Society of Interventional Oncology.mp4
Session 9 – Role of the Society of Interventional Radiology for the IO.mp4
Session 9 – Value Proposition in IO Selling It to the Hospital and Oncologists.mp4
Session 10 – Biliary Interventions in Hepatic Malignancies.mp4
Session 10 – Immunotherapy in IO Do Not Miss the Wave.mp4
Session 10 – Immunotherapy in IO Don’t Quit Your Day Job.mp4
Session 10 – Importance of Biopsy in the Era of Personalized Medicine.mp4
Session 11 – Bilateral Colorectal Lung Metastases Case Review Bad Outcomes and Whether They Could Have Been Avoided.mp4
Session 11 – Liver Case Review Bad Outcomes and Whether They Could Have Been Avoided.mp4
Session 11 – Lung Cancer Case Review Bad Outcomes and Whether They Could Have Been Avoided.mp4
Session 11 – M&M Hard Lessons from the World of IO Bad Outcomes and Whether They Could Have Been Avoided.mp4
Session 11 – Metastatic Bladder Cancer with Pathologic Fracture of the Acetabulum.mp4
Session 12 – Insanely Great Case Presentations in IO.mp4
Session 12 – Mesothelioma Subclavian Stent Case Presentation.mp4
Session 12 – Prolonged Pancreatic Leak Case Presentation.mp4

Reviews

There are no reviews yet.

Be the first to review “CIO Symposium on Clinical Interventional Oncology 2018”

Your email address will not be published. Required fields are marked *